Skip to main content
OpenTrials

Clinical trial condition

T-Cell Acute Lymphocytic Leukemia

Explore clinical trials studying T-Cell Acute Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

T-Cell Acute Lymphocytic Leukemia trial results

Recruiting

CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies

NCT06316856

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai Shanghai, Shanghai Municipality, China
  • Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China
  • The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China
View Trial Details
Recruiting

A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies

NCT07070323

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai Shanghai, Shanghai Municipality, China
  • Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China
  • The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China
View Trial Details

Related conditions